• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Peregrine Pharmaceuticals Inc

+ Add to Watchlist

PPHM:US

1.6200 USD 0.0200 1.22%

As of 09:50:05 ET on 08/22/2014.

Snapshot for Peregrine Pharmaceuticals Inc (PPHM)

Open: 1.6300 Day's Range: 1.6100 - 1.6500 Volume: 21,529
Previous Close: 1.6400 52wk Range: 1.1600 - 3.1800 1-Yr Rtn: +14.08%

Stock Chart for PPHM

No chart data available.
  • PPHM:US 1.6200
  • 1D
  • 1M
  • 1Y
1.6400
Interactive PPHM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PPHM

Current P/E Ratio (ttm) -
Estimated P/E(04/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2200
Est. EPS (USD) (04/2015) -0.2750
Est. PEG Ratio -
Market Cap (M USD) 293.90
Shares Outstanding (M) 179.21
30 Day Average Volume 1,039,058
Price/Book (mrq) 4.3068
Price/Sale (ttm) 11.7639
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PPHM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PPHM

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the research, development and commercialization of novel therapeutics for cancer and a wide range of viral diseases.

Steven W KingPresident/CEOPaul J LytleChief Financial Officer
Mark R ZiebellVP/Secretary/General CounselShelley P M FusseyVP:Intellectual Property
More Company Profile & Key Executives for PPHM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil